A chip-based multiplex molecular POCT detection platform utilizing PCR technology for detection of pathogens and genetic markers. Enables simultaneous detection of multiple targets in a single test.
Manufactured by
China
Xenta Biomedical Science Co., Ltd, founded in December 2021 and headquartered in Guangzhou Development District, is a national high-tech enterprise focused on the R&D, registration, and commercialization of in vitro diagnostic (IVD) reagents and devices. With fully paid-up capital of RMB 10 million, the company is led by a team of returnee PhDs with strong international research and industry experience. It is dedicated to developing innovative POCT technology platforms under the philosophy of "Faster, Better, and More Accessible". The company drives innovation through R&D centers in Guangzhou, Xiamen, and overseas. Using its proprietary dry light-excited chemiluminescence POCT platform, it has developed leading product series and managed major national research projects. The company has published over 20 SCI papers, holds 70 patents, has obtained more than 60 EU CE certifications, and 12 FDA approvals in the United States. Currently, several product lines are actively striving for NMPA certification. Its pipeline covers key areas including cardiovascular, inflammation, oncology, hormone, and infectious diseases, demonstrating end-to-end capabilities from R&D to global commercialization. The core team comprises graduates from top universities such as Texas A&M University, Xiamen University, Sanford-Burnham Medical Research Institute, and Sun Yat-sen University, possessing multidisciplinary expertise in biomedicine, engineering, and law. The co-founders have extensive experience from leading IVD companies, having previously guided teams to achieve annual revenues exceeding several hundred million yuan and secure over 200 product certifications worldwide. Since its establishment, Xenta Biomedical Science Co., Ltd has raised tens of millions in funding and obtained ISO 13485 certification, supporting its global expansion.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Ningbo Masschip Intelligent Technology Co., Ltd.
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Poly Diagnostics SARL
Luxembourg · 1 relevant product
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.
Germany · 1 relevant product
Coei Biotech
China · 1 relevant product
Guangdong Ascendas Genomics Technology Co., Ltd.
China · 2 relevant products
Fluxergy
United States · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Beijing Poly Microchip Techonology CO,.LTD
China · 1 relevant product
Shenzhen Diasia Biomedical Technology Co.,Ltd
China · 2 relevant products
28 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 44 closest product alternatives
Ningbo Masschip Intelligent Technology Co., Ltd. · China
Molecular diagnostic platform for polymerase chain reaction testing. Used for infectious disease detection and genetic analysis in clinical laboratories.
Anbio Biotechnology Limited · Germany
Simultaneous amplification system for detection of multiple pathogenic targets in single reaction. Increases testing efficiency and reduces turnaround time.
Poly Diagnostics SARL · Luxembourg
Multi-target real-time PCR diagnostic kits enabling simultaneous detection of multiple infectious agents. CE IVDR-marked and ISO 13485-certified for clinical diagnostics.
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. · Germany
Next-generation PCR and digital PCR (dPCR) platform enabling advanced multiplex diagnostics with microsystem technology. This integrated solution delivers faster turnaround times and improved accuracy for molecular diagnostics by combining precision thermal cycling with intelligent multiplexing capabilities. Designed to reduce complexity in laboratory workflows while maintaining diagnostic sensitivity and specificity.
Coei Biotech · China
Molecular diagnostic premix product supporting multiplex target amplification with high specificity and sensitivity down to 25 copies. Enables simultaneous detection of multiple pathogens in single samples.
Guangdong Ascendas Genomics Technology Co., Ltd. · China
Compatible probe and dye-based reagent system for microfluidic PCR analysis supporting flexible multi-plex molecular marker detection without pre-embedding.
Fluxergy · United States
Multiplex polymerase chain reaction assay capable of detecting 12 or more genetic markers simultaneously on a single test card. Delivers molecular nucleic acid detection results within one hour at point-of-care.
guangzhou biotron technolongy co.,ltd · China
A molecular diagnostic technique enabling detection of multiple targets within a single PCR reaction tube, improving efficiency and reducing sample requirements for complex diagnostic applications.
Beijing Poly Microchip Techonology CO,.LTD · China
Microfluidic devices integrated with PCR technology for gene amplification and molecular analysis. These platforms support high-throughput genetic testing and molecular diagnostic workflows.
Shenzhen Diasia Biomedical Technology Co.,Ltd · China
A molecular diagnostics system utilizing real-time PCR (polymerase chain reaction) technology for genetic and viral testing. The platform supports rapid detection and quantification of nucleic acids for various clinical applications.
DIA.PRO Diagnostic BioProbes Srl · Italy
A PCR-based diagnostic test for miscellaneous applications. This product enables molecular detection across various clinical scenarios using polymerase chain reaction technology.
Molecular Designs · United States
Multiplex PCR panels that enable simultaneous detection of multiple pathogens in a single assay. These panels streamline laboratory workflows while reducing reagent costs and sample processing time.
32 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products